Publications
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.2011 | First Faculty of Medicine
- IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Léčba revmatických onemocnění v průběhu gravidity a laktace2021 | First Faculty of Medicine
- The Children's rheumatology in practice2019 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development2017 | First Faculty of Medicine
- Pharmacotherapy of rheumatic diseases2017 | First Faculty of Medicine
- Systemic lupus erythematosus2017 | First Faculty of Medicine
- Glucocorticoids in systemic lupus erythematosus and possibilities of. Corticosteroid-sparing therapeutic regimens2015 | First Faculty of Medicine
- Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A2014 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Biological therapy of inflammatory autoimmune disease in rheumatology, gastroenterology and dermatology2014 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...